Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis

Surgical Oncology

Volumn 19, Issue 1, 2010, Pages

  Boutros, C ^a   Somasundar, P ^a   Garrean, S ^a   Saied, A ^a   Espat, N J ^a  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Ablation; Liver; Malignancy

Indexed keywords

CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DEVICE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LIVER TUMOR; MICROWAVE THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURVIVAL RATE; SURVIVAL TIME; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CAUTERIZATION; COLORECTAL TUMOR; DEVICES; LIVER NEOPLASMS; MICROWAVE RADIATION; PATHOLOGY; PROCEDURES; SECONDARY; THERAPEUTIC USE;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CAUTERY; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MICROWAVES;

EID: 75849126767     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2009.02.001     Document Type: Review

References (73)

1. McGlynn K.A., Tarone R.E., and El-Serag H.B. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 15 6 (2006) 1198-1203
2. Frezza E.E. Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses. Dig Dis Sci 49 5 (2004) 866-871
3. Ishizawa T., Hasegawa K., Aoki T., Takahashi M., Inoue Y., Sano K., et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134 7 (2008) 1908-1916 (Epub 2008 Mar 8)
4. Grazi G.L., Ercolani G., Pierangeli F., Del Gaudio M., Cescon M., Cavallari A., et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234 1 (2001) 71-78
5. Choti M.A., Sitzmann J.V., Tiburi M.F., Sumetchotimetha W., Rangsin R., Schulick R.D., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 6 (2002) 759-766
6. Adam R., de Haas R.J., Wicherts D.A., Aloia T.A., Delvart V., Azoulay D., et al. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?. J Clin Oncol 26 22 (2008) 3672-3680
7. Fong Y., Sun R.L., Jarnagin W., and Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229 6 (1999) 790-799 discussion 799-800
8. Poon R.T., and Fan S.T. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10 2 Suppl. 1 (2004) S39-S45
9. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzeti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 11 (1996) 693-699
10. Poon R.T., Fan S.T., Lo C.M., Liu C.L., Ng I.O., and Wong J. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 18 5 (2000) 1094-1101
11. Figueras J., Jaurrieta E., Valls C., Ramos E., Scrramo T., Rafccas A., et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 190 5 (2000) 580-587
12. Bismuth H., Majno P.E., and Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19 3 (1999) 311-322
13. Aloia T.A., Vauthey J.N., Loyer E.M., Ribero D., Pawlik T.M., Wei S.H., et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141 5 (2006) 460-466 discussion 466-7
14. Chun Y.S., Vauthey J.N., Ribero D., Donadon M., Mullen J.T., Eng C., et al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11 11 (2007) 1498-1504 discussion 1504-5. (Epub 2007 Sep 11)
15. Jarnagin W.R., Fong Y., Ky A., Schwartz L.H., Paty P.B., Cohen A.M., et al. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg 188 1 (1999) 33-42
16. Strasberg S.M., Dehdashti F., Siegel B.A., Drebin J.A., and Linehan D. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg 233 3 (2001) 293-299
17. Ruers T.J., Langenhoff B.S., Neeleman N., Jager G.J., Strijk S., Wobbs T., et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20 2 (2002) 388-395
18. Lubezky N., Metser U., Geva R., Nakache R., Shmueli E., Klausner J.M., et al. The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 11 4 (2007) 472-478
19. Raut C.P., Izzo F., Marra P., Ellis L.M., Vauthey J.N., Cremona F., et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 12 8 (2005) 616-628 (Epub 2005 Jun 20)
20. Amersi F.F., McElrath-Garza A., Ahmad A., Zogakis T., Allegra D.P., Krasne R., et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 141 6 (2006) 581-587 discussion 587-8
21. Lin S.M., Lin C.J., Lin C.C., Hsu C.W., and Chen Y.C. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54 8 (2005) 1151-1156
22. Shiina S., Teratani T., Obi S., Sato S., Tatcishi R., Fujishima T., et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129 1 (2005) 122-130
23. Lin S.M., Lin C.J., Lin C.C., Hsu C.W., and Chen Y.C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 127 6 (2004) 1714-1723
24. Buscarini L., Buscarini E., Di Stasi M., Vallisa D., Quaretti P., and Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11 6 (2001) 914-921
25. de Baere T., Elias D., Dromain C., Din M.G., Kuoch V., Ducreux M., et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 175 6 (2000) 1619-1625
26. Cabassa P., Donato F., Simeone F., Grazioli L., and Romanini L. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol 186 5 Suppl. (2006) S316-S321
27. Lencioni R., Cioni D., Crocetti L., Franchini C., Pina C.D., Lera J., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 3 (2005) 961-967 (Epub 2005 Jan 21)
28. Ng K.K., Poon R.T., Lo C.M., Yuen J., Tso W.K., and Fan S.T. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 12 1 (2008) 183-191 (Epub 2007 Sep 15)
29. Chung I.K., Park M.J., Kwon K.T., Park Y.D., Chung Y.J., Jeon S.W., et al. The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation. Korean J Hepatol 11 4 (2005) 371-380
30. Lu D.S., Yu N.C., Raman S.S., Limanond P., Lassman C., Murray K., et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234 3 (2005) 954-960 (Epub 2005 Jan 28)
31. Solbiati L., Ierace T., Goldberg S.N., Sironi S., Livraghi T., Fiocca R., et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 202 1 (1997) 195-203
32. Shah S.A., Greig P.D., Gallinger S., Cattral M.S., Dixon E., Kim R.D., et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202 2 (2006) 275-283 (Epub 2005 Dec 19)
33. Roayaie S., Haim M.B., Emre S., Fishbein T.M., Sheiner P.A., Miller C.M., et al. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol 7 10 (2000) 764-770
34. Schwartz M. Liver transplantation: the preferred treatment for early hepatocellular carcinoma in the setting of cirrhosis?. Ann Surg Oncol 14 2 (2007) 548-552 (Epub 2006 Sep 29)
35. Solbiati L., Livraghi T., Goldberg S.N., Terace T., Meloni F., Dellanoce M., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221 1 (2001) 159-166
36. Abdalla E.K., Vauthey J.N., Ellis L.M., Ellis V., Pollock R., Broglio K.R., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 6 (2004) 818-825 discussion 825-7
37. Scaife C.L., and Curley S.A. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am 12 1 (2003) 243-255
38. Livraghi T., Solbiati L., Meloni F., Ierace T., Goldberg S.N., and Gazelle G.S. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach. Cancer 97 12 (2003) 3027-3035
39. Figueras J., and Llado L. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time" approach. Cancer 98 10 (2003) 2303-2304 author reply 2304-5
40. Lencioni R., Crocetti L., Cioni D., Della Pina C., and Bartolozzi C. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 39 11 (2004) 689-697
41. Goldberg S.N., Hahn P.F., Tanabe K.K., Mueller P.R., Schima W., Athanasoulis C.A., et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol 9 1 Pt 1 (1998) 101-111
42. Cha C.H., Lee Jr. F.T., Gurney J.M., Markhardt B.K., Warner T.F., Kelcz F., et al. CT versus sonography for monitoring radiofrequency ablation in a porcine liver. AJR Am J Roentgenol 175 3 (2000) 705-711
43. Berber E., and Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol 15 10 (2008) 2757-2764 (Epub 2008 Jul 11)
44. Tabuse K., Katsumi M., Kobayashi Y., Noguchi H., Egawa H., Aoyama H., et al. Microwave surgery: hepatectomy using a microwave tissue coagulator. World J Surg 9 1 (1985) 136-143
45. Zhou X.D. Microwave surgery in the treatment of hepatic cancer. Zhonghua Wai Ke Za Zhi 31 3 (1993) 153-155
46. Simon C.J., Dupuy D.E., and Mayo-Smith W.W. Microwave ablation: principles and applications. Radiographics 25 Suppl. 1 (2005) S69-S83
47. Gravante G., Ong S.L., Metcalfe M.S., Strickland A., Dennison A.R., and Lloyd D.M. Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int 28 7 (2008) 911-921 (Epub 2008 Jun 28)
48. Lu M.D., Chen J.W., Xie X.Y., Liu L., Huang X.Q., Liang L.J., et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 221 1 (2001) 167-172
49. Shiina S., Teratani T., Obi S., Hamamura K., Koike Y., and Omata M. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 62 Suppl. 1 (2002) 64-68
50. Dong B., Liang P., Yu X., Su L., Yu D., Cheng Z., et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 180 6 (2003) 1547-1555
51. Liang P., Dong B., Yu X., Yu D., Wang Y., Feng L., et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 235 1 (2005) 299-307 (Epub 2005 Feb 24)
52. Dong B.W., Liang P., Yu X.L., Yu D.J., Zhang J., Feng L., et al. Long-term results of percutaneous sonographically-guided microwave ablation therapy of early-stage hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi 86 12 (2006) 797-800
53. Morita T., Shibata T., Okuyama M., Ikeda K., Tsukahara Y., Kitada M., et al. Microwave coagulation therapy for liver metastases from colorectal cancer. Gan To Kagaku Ryoho 31 5 (2004) 695-699
54. Seki S., Sakaguchi H., Iwai S., Kadoya H., Kabayashi S., Kitada T., et al. Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy. Endoscopy 37 12 (2005) 1220-1225
55. Stauffer P.R., Rossetto F., Prakash M., Neuman D.G., and Lee T. Phantom and animal tissues for modelling the electrical properties of human liver. Int J Hyperthermia 19 1 (2003) 89-101
56. Wright A.S., Lee Jr. F.T., and Mahvi D.M. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 10 3 (2003) 275-283
57. Yu N.C., Lu D.S., Raman S.S., Dupuy D.E., Simon C.J., Lassman C., et al. Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters - pilot comparison with pathologic findings. Radiology 239 1 (2006) 269-275 (Epub 2006 Feb 21)
58. Simon C.J., Dupuy D.E., Iannitti D.A., Lu D.S., Yu N.C., Aswad B.I., et al. Intraoperative triple antenna hepatic microwave ablation. AJR Am J Roentgenol 187 4 (2006) W333-W340
59. Iannitti D.A., Martin R.C., Simon C.J., Hope W.W., Newcomb W.L., McMasters K.M., et al. Hepatic tumor ablation with clustered microwave antennae: the US Phase II Trial. HPB (Oxford) 9 2 (2007) 120-124
60. Hope W.W., Schmelzer T.M., Newcomb W.L., Heath J.J., Lincourt A.E., Norton H.J., et al. Guidelines for power and time variables for microwave ablation in a porcine liver. J Gastrointest Surg 12 3 (2008) 463-467 (Epub 2007 Sep 6)
61. Seki T., Wakabayashi M., Nakagawa T., Imamura M., Tamai T., Nishimura A., et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 85 8 (1999) 1694-1702
62. Shibata T., Iimuro Y., Yamamoto Y., Maetani Y., Ametani F., Itoh K., et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223 2 (2002) 331-337
63. Xu H.X., Lu M.D., Xie X.Y., Yin X.Y., Kuang M., Chen J.W., et al. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Clin Radiol 60 9 (2005) 1018-1025
64. Lu M.D., Xu H.X., Xie X.Y., Yin X.Y., Chen J.W., Kuang M., et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 40 11 (2005) 1054-1060
65. Ohmoto K., Yoshioka N., Tomiyama Y., Shibata N., Kawase T., Yoshida K., et al. Thermal ablation therapy for hepatocellular carcinoma: comparison between radiofrequency ablation and percutaneous microwave coagulation therapy. Hepatogastroenterology 53 71 (2006) 651-654
66. Shibata T., Niinobu T., Ogata N., and Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89 2 (2000) 276-284
67. Garrean S., Hering J., Saied A., Helton W.S., and Espat N.J. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195 4 (2008) 508-520
68. Siperstein A.E., Berber E., Ballem N., and Parikh R.T. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 246 4 (2007) 559-565 discussion 565-7
69. Garrean S., Hering J., Saied A., Hoopes P.J., Helton W.S., Ryan T.P., et al. Ultrasound monitoring of a novel microwave ablation (MWA) device in porcine liver: lessons learned and phenomena observed on ablative effects near major intrahepatic vessels. J Gastrointest Surg 21 (2008) 21
70. Shiomi H., Naka S., Sato K., Demura K., Murakami K., Shimizu T., et al. Thoracoscopy-assisted magnetic resonance guided microwave coagulation therapy for hepatic tumors. Am J Surg 195 6 (2008) 854-860 Epub 2008 Mar 26
71. Ogata Y., Uchida S., Hisaka T., Horiuchi H., Mori S., Ishibashi N., et al. Intraoperative thermal ablation therapy for small colorectal metastases to the liver. Hepatogastroenterology 55 82-83 (2008) 550-556
72. Ohmoto K., and Yamamoto S. Comparison between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. Clin Radiol 61 9 (2006) 800-801 author reply 801-2
73. Liang P., Dong B., Yu X., Yang Y., Yu D., Su L., et al. Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol 181 5 (2003) 1319-1325